Integer Completes Two Facility Expansions in Ireland

Integer Holdings Corporation a leading medical device contract development and manufacturing organization (CDMO), announced the completion of its facility expansions in Ireland. 
 
Integer opened its new European medical device innovation and manufacturing center in Galway, Ireland. This followed the official opening of an 80,000 sq. ft. expansion of Integer’s guidewire manufacturing facility in New Ross, County Wexford, Ireland, earlier this month.
 
“Our expansion in Ireland provides Integer with the capacity and differentiated capabilities to amplify our customers’ innovation and help them bring products to market faster,” said Joseph Dziedzic, Integer President and CEO. “Integer’s significant investment in Ireland demonstrates our commitment to supporting our customers’ growth and furthers our unparalleled ability to be their partner of choice for developing the next generation of lifesaving and life-enhancing medical therapies.”
 
Integer’s new $30 million, 67,000 sq. ft. facility in the Parkmore East area of Galway will support the increasing demand for regional research, development, and manufacturing as well as additional capacity for catheters, medical textiles, and delivery systems. The manufacturing space in the same facility allows a seamless transition of new products from development to manufacturing, further enabling Integer’s ability to help customers bring products to market faster. 
 
While this initial phase of development satisfies immediate needs, the company has obtained planning permission for a total of 147,000 sq. ft. of space at the Parkmore East location and, subject to planning permission, has enough space to grow that facility’s manufacturing footprint to 300,000 sq. ft.
 
In addition to the new facility in Galway, Integer has completed a $60 million capital investment in its facility in New Ross, County Wexford. This investment increases manufacturing capacity at the New Ross site by more than 70%, adding 80,000 sq. ft. to the current facility, bringing the total square footage to 215,000, and includes new state-of-the-art manufacturing equipment to support customers’ long-term growth.
 
In 2022, Integer acquired Aran Biomedical, a leader in proprietary medical textiles, high-precision biomaterial coverings and coatings, and advanced metal and polymer braiding, based in Spiddal. The $140 million acquisition has since furthered Integer’s ability to provide highly differentiated, proprietary biomaterial technologies for implantable cardiovascular devices to enable customers’ innovation globally.
 
“Since Integer, then Lake Region Medical, first expanded into Ireland 30 years ago, our local team of talented professionals has partnered with leading medical device companies to develop and supply innovative, high-quality products to customers around the globe,” said John Harris, Integer Executive Vice President, Global Operations and Manufacturing Strategy. “We are excited about the expansion of our development and manufacturing network in Ireland and look forward to continued growth as we strengthen our ability to support our customers’ long-term strategy and technology needs, both in Ireland and globally.”
 
IDA Ireland CEO Michael Lohan said, “Integer’s continuing expansion in Ireland, following 30 years of success here, is a wonderful vote of confidence in the strong business growth opportunities that Ireland offers. The new manufacturing facility in Galway and the expansion in Wexford highlight the skills and talent that our regional locations can offer the medical technology sector. IDA Ireland is committed to bringing high quality investment to regional locations around Ireland. I wish the Integer team continued success.”